News & Articles

New blood test is designed to reduce the number of false positive results and provide improved diagnostic guidance in Systemic Lupus Erythematosus

Fusion Antibodies and Eurofins Discovery sign co-marketing agreement to support timely and cost-effective development of innovative products for the benefit of global healthcare.

The new MaxSignal Mycotoxin Automation Bundle enables faster time to result, lower cost per sample and increased productivity

The new all-in-one digital inspection solution from Leica Microsystems

Experience the solutions new functions with a free trial on the Aivia web platform

The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories

The quantum cascade laser (QCL) is designed by leveraging unique micro-electro-mechanical system (MEMS) technology

The solution has already been deployed in several clinical diagnostic laboratories to drive efficiency and aid the identification of Covid positive cases in the fight against the global pandemic

The new Thermo Scientific Vanquish Method Development HPLC and UHPLC system delivers robust and validated methods in less time with higher confidence

Vets can see for themselves how easy it is to do in-house PCR testing using POCKIT Central PCR analyzer

A complete workflow developed by Promega creates a snapshot of community-wide infection rates using wastewater samples

STRmix forensic software is highly effective in interpreting complex DNA evidence

ExoBrite EV membrane staining kits for specific and versatile detection of extracellular vesicles by flow cytometry

High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection

Value of in-house PCR analysis for pathogen testing highlighted at recent veterinary CPD webinar discussing the importance of screening imported dogs

The CytoSMART Lux3 BR is a small brightfield microscope equipped with a high-quality 6.4 MP CMOS camera

Will enable cancer researchers to accelerate identification and optimization of therapeutic leads by better decoding KRAS mutations present in 25% of tumors